These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 23573546

  • 1. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M, Gutteridge W, Zeman A, Dickins M, Woolley JL.
    J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [Abstract] [Full Text] [Related]

  • 2. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG, Looareesuwan S, Chulay JD.
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [Abstract] [Full Text] [Related]

  • 3. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD, Kremsner PG, Sukwa TY, van der Berg JD, Shapiro TA, Scott TR, Chulay JD, Malarone Clinical Trials Study Group.
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [Abstract] [Full Text] [Related]

  • 4. Clinical pharmacology of atovaquone and proguanil hydrochloride.
    Beerahee M.
    J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547
    [Abstract] [Full Text] [Related]

  • 5. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K, Scott L.
    Drugs; 2003 May; 63(6):597-623. PubMed ID: 12656656
    [Abstract] [Full Text] [Related]

  • 6. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
    Deye GA, Miller RS, Miller L, Salas CJ, Tosh D, Macareo L, Smith BL, Fracisco S, Clemens EG, Murphy J, Sousa JC, Dumler JS, Magill AJ.
    Clin Infect Dis; 2012 Jan 15; 54(2):232-9. PubMed ID: 22052893
    [Abstract] [Full Text] [Related]

  • 7. Cytogenetic and oxidative status of human lymphocytes after exposure to clinically relevant concentrations of antimalarial drugs atovaquone and proguanil hydrochloride in vitro.
    Dinter D, Gajski G, Domijan AM, Garaj-Vrhovac V.
    Fundam Clin Pharmacol; 2015 Dec 15; 29(6):575-85. PubMed ID: 26434663
    [Abstract] [Full Text] [Related]

  • 8. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct 15; 11(61):131-6. PubMed ID: 12378742
    [Abstract] [Full Text] [Related]

  • 9. Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection.
    Visser R, de Mast Q, Munnix I, van der Ven A, Dofferhoff T.
    Travel Med Infect Dis; 2016 Oct 15; 14(6):644-645. PubMed ID: 27546283
    [No Abstract] [Full Text] [Related]

  • 10. Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb.
    Teo BH, Lansdell P, Smith V, Blaze M, Nolder D, Beshir KB, Chiodini PL, Cao J, Färnert A, Sutherland CJ.
    PLoS Negl Trop Dis; 2015 Oct 15; 9(10):e0004068. PubMed ID: 26485258
    [Abstract] [Full Text] [Related]

  • 11. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
    Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB.
    Am J Trop Med Hyg; 1999 Apr 15; 60(4):533-41. PubMed ID: 10348225
    [Abstract] [Full Text] [Related]

  • 12. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
    Boggild AK, Parise ME, Lewis LS, Kain KC.
    Am J Trop Med Hyg; 2007 Feb 15; 76(2):208-23. PubMed ID: 17297027
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa.
    Leshem E, Meltzer E, Stienlauf S, Kopel E, Schwartz E.
    J Travel Med; 2014 Feb 15; 21(2):82-5. PubMed ID: 24298915
    [Abstract] [Full Text] [Related]

  • 14. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
    Lell B, Luckner D, Ndjavé M, Scott T, Kremsner PG.
    Lancet; 1998 Mar 07; 351(9104):709-13. PubMed ID: 9504515
    [Abstract] [Full Text] [Related]

  • 15. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
    Sutherland CJ, Laundy M, Price N, Burke M, Fivelman QL, Pasvol G, Klein JL, Chiodini PL.
    Malar J; 2008 Nov 20; 7():240. PubMed ID: 19021900
    [Abstract] [Full Text] [Related]

  • 16. Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options.
    Meltzer E, Rahav G, Schwartz E.
    Clin Infect Dis; 2018 May 17; 66(11):1751-1755. PubMed ID: 29228132
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
    Thapar MM, Gupta S, Spindler C, Wernsdorfer WH, Björkman A.
    Trans R Soc Trop Med Hyg; 2003 May 17; 97(3):331-7. PubMed ID: 15228254
    [Abstract] [Full Text] [Related]

  • 18. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J, Baird JK, Fryauff DJ, Sismadi P, Bangs MJ, Lacy M, Barcus MJ, Gramzinski R, Maguire JD, Kumusumangsih M, Miller GB, Jones TR, Chulay JD, Hoffman SL, Naval Medical Research Unit 2 Clinical Trial Team.
    Clin Infect Dis; 2002 Oct 01; 35(7):825-33. PubMed ID: 12228819
    [Abstract] [Full Text] [Related]

  • 19. Atovaquone-proguanil for prophylaxis and treatment of malaria.
    Marra F, Salzman JR, Ensom MH.
    Ann Pharmacother; 2003 Sep 01; 37(9):1266-75. PubMed ID: 12921511
    [Abstract] [Full Text] [Related]

  • 20. Abbreviated atovaquone-proguanil prophylaxis regimens in travellers after leaving malaria-endemic areas: A systematic review.
    Savelkoel J, Binnendijk KH, Spijker R, van Vugt M, Tan K, Hänscheid T, Schlagenhauf P, Grobusch MP.
    Travel Med Infect Dis; 2018 Sep 01; 21():3-20. PubMed ID: 29242073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.